Maze Therapeutics (MAZE) Stock: Buy, Sell, or Hold?
MAZE - Maze Therapeutics, Inc. Common Stock
$31.01
-0.94 (-2.94%)
▼
5d:
+12.64%
30d:
+18.31%
90d:
+8.09%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
11d
Get Alerted When MAZE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MAZE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MAZE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MAZE is currently trading at $31.01, which is considered extended relative to its 30-day fair value range of $24.32 to $28.42.
Technical Outlook: Technically, MAZE is in a uptrend. Immediate support is located at $25.96, while resistance sits at $33.19.
Market Sentiment: MAZE scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.54 (+101.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MAZE is in a uptrend. Immediate support is located at $25.96, while resistance sits at $33.19.
Market Sentiment: MAZE scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.54 (+101.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.32 -
$28.42
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+9.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 101.7% below Wall St target ($62.54)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$24.32 -
$28.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.97
Resistance Level
$33.19
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.73
Wall Street Target
$62.54
(+101.7%)
Share & Embed Analysis
Last updated: October 23, 2026 7:41 PM ET
Data refreshes hourly during market hours. Next update: 8:41 PM
Data refreshes hourly during market hours. Next update: 8:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAZE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 53 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 64 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 59 HOLD |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
